nitrous oxide has been researched along with Developmental Disabilities in 4 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study was to compare the end-tidal sevoflurane concentration and time for intravenous cannulation at induction of anesthesia using sevoflurane with or without nitrous oxide in healthy children and in those with developmental disabilities." | 8.12 | Sevoflurane concentration for cannulation in developmental disabilities. ( Hitosugi, T; Kunihiro, N; Miki, Y; Taura, S; Tsukamoto, M; Yokoyama, T, 2022) |
| "The goal of this study was to compare the end-tidal sevoflurane concentration and time for intravenous cannulation at induction of anesthesia using sevoflurane with or without nitrous oxide in healthy children and in those with developmental disabilities." | 4.12 | Sevoflurane concentration for cannulation in developmental disabilities. ( Hitosugi, T; Kunihiro, N; Miki, Y; Taura, S; Tsukamoto, M; Yokoyama, T, 2022) |
| "After exposure to nitrous oxide, an infant with unrecognized cobalamin deficiency developed neurologic deterioration and pancytopenia." | 3.70 | Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. ( Felmet, K; Hayflick, SJ; Robins, B; Tilford, D, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunihiro, N | 1 |
| Tsukamoto, M | 1 |
| Taura, S | 1 |
| Hitosugi, T | 1 |
| Miki, Y | 1 |
| Yokoyama, T | 1 |
| Casado, AI | 1 |
| Ruiz, J | 1 |
| Oro, J | 1 |
| MartÃnez, C | 1 |
| Fernández, I | 1 |
| Oliva, P | 1 |
| Taylor, DJ | 1 |
| Nelson, J | 1 |
| Howie, PW | 1 |
| Felmet, K | 1 |
| Robins, B | 1 |
| Tilford, D | 1 |
| Hayflick, SJ | 1 |
4 other studies available for nitrous oxide and Developmental Disabilities
| Article | Year |
|---|---|
Sevoflurane concentration for cannulation in developmental disabilities.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Catheterization; Child; Developmental Disabilities; | 2022 |
Anaesthetic management in a case of Kabuki syndrome.
Topics: Abnormalities, Multiple; Adjuvants, Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; A | 2004 |
Neurodevelopmental disability--a sibling-control study.
Topics: Anesthesia, Obstetrical; Case-Control Studies; Child, Preschool; Developmental Disabilities; Drug Co | 1993 |
Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide.
Topics: Anemia, Megaloblastic; Anesthetics, Inhalation; Athetosis; Developmental Disabilities; Fatigue; Feve | 2000 |